Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study

Background. Traditional Chinese medicine (TCM) has long been widely adopted by the Chinese people and has been covered by China’s basic medical insurance schemes to treat ischemic stroke. Previous research has mainly highlighted the therapy effect of TCM on ischemic stroke patients. Some studies hav...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhengwei Huang, Xuefeng Shi, Stephen Nicholas, Elizabeth Maitland, Yong Yang, Weihan Zhao, Yong Ma, Yan Jiang
Formato:	article
Lenguaje:	EN
Publicado:	Hindawi Limited 2021
Materias:	Other systems of medicine RZ201-999
Acceso en línea:	https://doaj.org/article/0f6094958fd240abb8b7d15b26002e22
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0f6094958fd240abb8b7d15b26002e22
record_format	dspace
spelling	oai:doaj.org-article:0f6094958fd240abb8b7d15b26002e222021-11-08T02:35:36ZUse of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study1741-428810.1155/2021/8554829https://doaj.org/article/0f6094958fd240abb8b7d15b26002e222021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/8554829https://doaj.org/toc/1741-4288Background. Traditional Chinese medicine (TCM) has long been widely adopted by the Chinese people and has been covered by China’s basic medical insurance schemes to treat ischemic stroke. Previous research has mainly highlighted the therapy effect of TCM on ischemic stroke patients. Some studies have demonstrated that employing TCM can reduce the medical burden on other diseases. But no research has explored whether using TCM could reduce inpatient medical cost for ischemic stroke in mainland China. The purpose of this study is to investigate the impact of the use of TCM on the total inpatient cost of ischemic stroke and to explore whether TCM has played the role of being complementary to, or an alternative for, conventional medicine to treat ischemic stroke. Methods. We conducted a national cross-sectional analysis based on a 5% random sample from claims data of China Urban Employee Basic Medical Insurance (UEBMI) and Urban Resident Basic Medical Insurance (URBMI) schemes in 2015. Mann–Whitney test was used to compare unadjusted total inpatient cost, conventional medication cost, and nonpharmacy cost estimates. Ordinary least square regression analysis was performed to compare demographics-adjusted total inpatient cost and to examine the association between TCM cost and conventional medication cost. Results. A total of 47321 urban inpatients diagnosed with ischemic stroke were identified in our study, with 92.6% (43843) of the patients using TCM in their inpatient treatment. Total inpatient cost for TCM users was significantly higher than TCM nonusers (USD 1217 versus USD 1036, P<0.001). Conventional medication cost was significantly lower for TCM users (USD 335 versus USD 436, P<0.001). The average cost of TCM per patient among TCM users was USD 289. Among TCM users, conventional medication costs were found to be positively associated with TCM cost after adjusting for confounding factors (Coef. = 0.144, P<0.001). Conclusion. Although the use of TCM reduced the cost of conventional medicine compared with TCM nonusers, TCM imposed an extra financial component on the total inpatient cost on TCM users. Our study suggests that TCM mainly played a complementary role to conventional medicine in ischemic stroke treatment in mainland China.Zhengwei HuangXuefeng ShiStephen NicholasElizabeth MaitlandYong YangWeihan ZhaoYong MaYan JiangHindawi LimitedarticleOther systems of medicineRZ201-999ENEvidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Other systems of medicine RZ201-999
spellingShingle	Other systems of medicine RZ201-999 Zhengwei Huang Xuefeng Shi Stephen Nicholas Elizabeth Maitland Yong Yang Weihan Zhao Yong Ma Yan Jiang Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
description	Background. Traditional Chinese medicine (TCM) has long been widely adopted by the Chinese people and has been covered by China’s basic medical insurance schemes to treat ischemic stroke. Previous research has mainly highlighted the therapy effect of TCM on ischemic stroke patients. Some studies have demonstrated that employing TCM can reduce the medical burden on other diseases. But no research has explored whether using TCM could reduce inpatient medical cost for ischemic stroke in mainland China. The purpose of this study is to investigate the impact of the use of TCM on the total inpatient cost of ischemic stroke and to explore whether TCM has played the role of being complementary to, or an alternative for, conventional medicine to treat ischemic stroke. Methods. We conducted a national cross-sectional analysis based on a 5% random sample from claims data of China Urban Employee Basic Medical Insurance (UEBMI) and Urban Resident Basic Medical Insurance (URBMI) schemes in 2015. Mann–Whitney test was used to compare unadjusted total inpatient cost, conventional medication cost, and nonpharmacy cost estimates. Ordinary least square regression analysis was performed to compare demographics-adjusted total inpatient cost and to examine the association between TCM cost and conventional medication cost. Results. A total of 47321 urban inpatients diagnosed with ischemic stroke were identified in our study, with 92.6% (43843) of the patients using TCM in their inpatient treatment. Total inpatient cost for TCM users was significantly higher than TCM nonusers (USD 1217 versus USD 1036, P<0.001). Conventional medication cost was significantly lower for TCM users (USD 335 versus USD 436, P<0.001). The average cost of TCM per patient among TCM users was USD 289. Among TCM users, conventional medication costs were found to be positively associated with TCM cost after adjusting for confounding factors (Coef. = 0.144, P<0.001). Conclusion. Although the use of TCM reduced the cost of conventional medicine compared with TCM nonusers, TCM imposed an extra financial component on the total inpatient cost on TCM users. Our study suggests that TCM mainly played a complementary role to conventional medicine in ischemic stroke treatment in mainland China.
format	article
author	Zhengwei Huang Xuefeng Shi Stephen Nicholas Elizabeth Maitland Yong Yang Weihan Zhao Yong Ma Yan Jiang
author_facet	Zhengwei Huang Xuefeng Shi Stephen Nicholas Elizabeth Maitland Yong Yang Weihan Zhao Yong Ma Yan Jiang
author_sort	Zhengwei Huang
title	Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
title_short	Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
title_full	Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
title_fullStr	Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
title_full_unstemmed	Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study
title_sort	use of traditional chinese medicine and its impact on medical cost among urban ischemic stroke inpatients in china: a national cross-sectional study
publisher	Hindawi Limited
publishDate	2021
url	https://doaj.org/article/0f6094958fd240abb8b7d15b26002e22
work_keys_str_mv	AT zhengweihuang useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy AT xuefengshi useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy AT stephennicholas useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy AT elizabethmaitland useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy AT yongyang useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy AT weihanzhao useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy AT yongma useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy AT yanjiang useoftraditionalchinesemedicineanditsimpactonmedicalcostamongurbanischemicstrokeinpatientsinchinaanationalcrosssectionalstudy
_version_	1718443161434456064

Use of Traditional Chinese Medicine and Its Impact on Medical Cost among Urban Ischemic Stroke Inpatients in China: A National Cross-Sectional Study

Ejemplares similares